Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,574,867
+$62,762 QoQ
Shares Held
6,201
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.39%
of 13F equity value
Holder Rank
#2,561
of 4,676 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MRP Capital Investments, LLC holds $6,725,014 across 7 Drug Manufacturers - General names. JNJ ranks #2 (23.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,932 | $3,516,728 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
6,201 | $1,574,867 | |
| 3 | PFE |
Pfizer Inc
|
47,847 | $1,152,155 | |
| 4 | AMGN |
Amgen Inc
|
650 | $235,378 | |
| 5 | ABBV |
AbbVie Inc.
|
512 | $128,839 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
900 | $113,706 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
58 | $3,341 |
All Filings in JNJ
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,574,867 | 6,201 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,512,105 | 6,186 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,261,360 | 6,095 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $792,670 | 4,275 | Shares | Sole | 2025-12-08 | |
| 2025-06-30 | $670,571 | 4,390 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $480,936 | 2,900 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $237,176 | 1,640 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $255,244 | 1,575 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $271,857 | 1,860 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $353,554 | 2,235 | Shares | Sole | 2024-05-08 | |
| 2023-09-30 | $1,646,121 | 10,569 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $829,751 | 5,013 | Shares | Sole | 2023-07-24 | |
| 2022-12-31 | $1,417,262 | 8,023 | Shares | Defined | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||